Holen Sie sich die Stockscreener-App
2.28
10.68%
0.22
Handel nachbörslich:
2.30
0.02
+0.88%
Finanzdaten der Taysha Gene Therapies Inc-Aktie (TSHA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
5.36%
3.411
|
3.604 | 4.746 | 2.395 | 4.706 |
Operating Expenses
|
39.75%
27.74
|
19.85 | 21.00 | 25.78 | 21.27 |
| Interest Income/Expense |
95.93%
0.029
|
0.713 | 1.471 | 1.44 | 1.374 |
| Benefits Costs and Expenses |
162.24%
27.47
|
-44.14 | - | - | 22.33 |
| Costs And Expenses |
162.24%
27.47
|
-44.14 | 21.00 | 25.78 | 22.33 |
| Operating Income/Loss |
49.76%
-24.33
|
-16.25 | -16.25 | -23.38 | -16.56 |
| Nonoperating Income/Loss |
99.58%
0.269
|
63.99 | -100.84 | -1.214 | -1.063 |
| Income/Loss From Continuing Operations Before Tax |
150.40%
-24.06
|
47.74 | 4.746 | 2.395 | -17.62 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
150.40%
-24.06
|
47.74 | -117.09 | -24.60 | -17.62 |
|
Net Income/Loss
|
150.40%
-24.06
|
47.74 | -117.09 | -24.60 | -17.62 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
634.34%
231.25
|
31.49 | 125.70 | 64.24 | 63.26 |
| Diluted Average Shares |
634.34%
231.25
|
31.49 | 125.70 | 64.24 | 63.26 |
| Basic Earnings Per Share |
110.87%
-0.10
|
0.92 | -0.93 | -0.38 | -0.28 |
| Diluted Earnings Per Share |
110.87%
-0.10
|
0.92 | -0.93 | -0.38 | -0.28 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):